World Health Organization
Mid-term Evaluation of the WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases: report
23 Jan 2025
Between 10 March and 20 April 2023, the ACCISS Study took a global snapshot of the prices people currently pay for glargine insulin and its affordability. Individuals from 47 countries collected the full price for all glargine products found in their closest private pharmacy and/or public sector pharmacy. While these prices should not be considered representative of the country (as inter-country price variation often exists), they provide a point-in-time depiction of what people currently pay.